Evaluation of Renografin M-76 as a contrast agent for angiocardiography.
D000606:Amino Sugars / Q000633:toxicity*; D000790:Angiocardiography; D000818:Animals; D001027:Aortography; D001565:Benzoates / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002021:Buffers; D002533:Cerebral Angiography; D014695:Cerebral Ventriculography; D003973:Diatrizoate / Q000008:administration & dosage / Q000633:toxicity*; D004285:Dogs; D004562:Electrocardiography; D004594:Electrophysiology; D005069:Evaluation Studies as Topic; D006327:Heart Block / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D012972:Sodium Hydroxide; D014693:Ventricular Fibrillation / Q000139:chemically induced
D000606:Amino Sugars; D001565:Benzoates; D002021:Buffers; D003973:Diatrizoate; D012972:Sodium Hydroxide